Strategic life sciences marketing agency ramarketing has completed the acquisition of ISR Market Research, a specialist agency based in North Carolina’s Research Triangle Park (RTP), one of the largest pharmaceutical and biopharma hubs in North America.

战略生命科学营销机构 ramarketing 已完成对 ISR Market Research 的收购，这是一家位于北卡罗来纳州研究三角园区（RTP）的专门机构，该园区是北美最大的制药和生物制药中心之一。

The deal strengthens ramarketing’s North American presence while bringing together specialist market intelligence with strategy and marketing activation.

该交易加强了 ramarketing 在北美的影响力，同时将专业的市场情报与战略和营销激活结合在一起。

ISR is recognized for its primary research-led syndicated and custom market research for the pharmaceutical outsourcing market, including Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs). As part of the transaction, ISR will retain its brand, structure, and leadership, with CEO Kate Hammeke continuing in her role..

ISR因其在制药外包市场的主要研究主导的联合和定制市场研究而受到认可，其中包括合同开发和制造组织（CDMO）和合同研究组织（CRO）。作为交易的一部分，ISR将保留其品牌、结构和领导层，首席执行官凯特·哈姆克将继续担任她的职务。

Emma Banks, Group CEO at ramarketing, said: “ISR adds depth to our commercial offer in a way that is practical and client-led. Its research capability strengthens how we help clients make informed growth decisions, while keeping insight, strategy, and execution closely aligned.”

ramarketing集团首席执行官艾玛·班克斯表示：“ISR以一种实用且客户为导向的方式，深化了我们的商业服务。其研究能力增强了我们帮助客户做出明智增长决策的能力，同时确保洞察、战略和执行紧密协调。”

“One of the most exciting aspects of this partnership is the depth of insight ISR brings. Their research connects us directly with thousands of pharma and biotech buyers across the outsourcing market, creating a powerful database of evidence that will help our clients make better strategic decisions.”.

“此次合作最令人兴奋的方面之一是ISR带来的深度洞察。他们的研究使我们直接与外包市场上的数千名制药和生物技术买家建立联系，创建一个强大的证据数据库，将帮助我们的客户做出更好的战略决策。”

“This is a capability-led investment rather than a structural overhaul. ISR retains its identity and research integrity, while gaining access to broader commercial support as part of the group.”

“这是一项以能力为导向的投资，而非结构性改革。ISR保持其身份和研究的完整性，同时作为集团的一部分获得更广泛的商业支持。”

Kate Hammeke, CEO of ISR, said: “ISR has built its reputation on rigorous primary research and trusted insight for the pharma outsourcing sector. Being part of ramarketing allows us to extend the impact of that work, giving clients stronger support in acting on insight without changing how we conduct or deliver our research.”.

凯特·哈姆克（Kate Hamke），ISR的首席执行官表示：“ISR在制药外包领域的严谨的初步研究和可信赖的洞察力方面建立了声誉。成为ramarketing的一部分，可以让我们扩大这些工作的影响力，在不改变我们进行或交付研究方式的前提下，为客户提供更有力的支持以采取行动。”

“Our team, methodologies, and client relationships remain unchanged. What expands is the range of support available to clients as they translate research into commercial decisions.”

“我们的团队、方法和客户关系保持不变。扩大的是客户将研究转化为商业决策时可获得的支持范围。”

The move brings together ISR’s research and insight capability with ramarketing’s strategy, marketing, and communications expertise. The combined capabilities will support clients from evidence generation and market insight through to positioning, go-to-market strategy, and activation.

该举措将ISR的研究和洞察力与ramarketing的战略、营销和传播专业知识结合在一起。综合能力将支持客户从证据生成和市场洞察到定位、上市策略和激活的全过程。

ramarketing works with pharmaceutical services and outsourcing organizations across Europe and North America, providing strategy, marketing, communications, and creative support to fuel growth. The business has grown steadily in recent years, supporting clients across CDMO, CRO, and wider pharmaceutical services, and now operates with a broader international footprint following the acquisition of ISR..

ramarketing为欧洲和北美的制药服务和外包组织提供战略、营销、传播和创意支持，助力业务增长。近年来，该企业稳步发展，服务于CDMO、CRO及更广泛的制药服务领域客户，并在收购ISR后进一步拓展了国际业务版图。

Liam May from ramarketing’s investment partner, NorthEdge, said: “This acquisition strengthens the group’s ability to support evidence-led decision-making across the pharma services market and reflects a clear focus on building differentiated capability – reinforcing ramarketing’s position as a leading, data-driven commercial partner for life sciences clients globally.”.

北缘资本（NorthEdge）作为ramarketing的投资合作伙伴，其代表利亚姆·梅表示：“此次收购增强了该集团在制药服务市场支持基于证据的决策的能力，并体现了其打造差异化能力的明确重点——进一步巩固了ramarketing作为全球生命科学客户领先的、数据驱动的商业合作伙伴地位。”

Alvarez & Marsal acted as corporate finance adviser to ramarketing, alongside Cortus (financial), Addleshaw Goddard and Rich May (UK and U.S. legal).

阿尔瓦雷斯和马萨尔公司担任了ramarketing的企业财务顾问，同时还有Cortus（财务）、Addleshaw Goddard和Rich May（英国和美国法律）。

For more information, visit www.ramarketingpr.com and https://isrreports.com/

欲了解更多信息，请访问 www.ramarketingpr.com 和 https://isrreports.com/

About the ramarketing Group

关于ramarketing集团

ramarketing and ISR together form a specialist commercial growth partner for the pharmaceutical outsourcing industry, uniting insight-led market research with commercial marketing strategy and execution. The combined group serves pharma services organizations with syndicated and custom primary research, strategic positioning, marketing, and PR designed to support better decision-making and drive measurable commercial impact.

ramarketing 和 ISR 共同构成了制药外包行业的专业商业增长合作伙伴，将洞察引导的市场研究与商业营销战略和执行相结合。联合集团为制药服务组织提供联合和定制的初步研究、战略定位、营销和公共关系服务，旨在支持更好的决策制定并推动可衡量的商业影响。

Smarter questions. Smarter answers. Stronger commercial outcomes..

更明智的问题，更明智的答案，更强的商业成果。